메뉴 건너뛰기




Volumn 63, Issue 8, 2016, Pages 1056-1062

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States

Author keywords

Benznidazole; Chagas disease; Nifurtimox; Side effects; Trypanosoma cruzi

Indexed keywords

NIFURTIMOX; ANTITRYPANOSOMAL AGENT;

EID: 84990877543     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw477     Document Type: Article
Times cited : (80)

References (32)
  • 2
    • 77953028103 scopus 로고    scopus 로고
    • Chagas disease: A Latin American health problem becoming a world health problem
    • Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010; 115:14-21.
    • (2010) Acta Trop , vol.115 , pp. 14-21
    • Schmunis, G.A.1    Yadon, Z.E.2
  • 3
    • 70149108335 scopus 로고    scopus 로고
    • An estimate of the burden of Chagas disease in the United States
    • Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49:e52-4.
    • (2009) Clin Infect Dis , vol.49 , pp. e52-e54
    • Bern, C.1    Montgomery, S.P.2
  • 4
    • 84937002067 scopus 로고    scopus 로고
    • Access to care for Chagas disease in the United States: A health systems analysis
    • Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg 2015; 93:5.
    • (2015) Am J Trop Med Hyg , vol.93 , pp. 5
    • Manne-Goehler, J.1    Reich, M.R.2    Wirtz, V.J.3
  • 5
    • 84875614866 scopus 로고    scopus 로고
    • Global economic burden of Chagas disease: A computational simulation model
    • Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 2013; 13:342-8.
    • (2013) Lancet Infect Dis , vol.13 , pp. 342-348
    • Lee, B.Y.1    Bacon, K.M.2    Bottazzi, M.E.3    Hotez, P.J.4
  • 8
    • 79959793199 scopus 로고    scopus 로고
    • Antitrypanosomal therapy for Chagas' disease
    • Bern C. Antitrypanosomal therapy for Chagas' disease. N Engl J Med 2011; 364:7.
    • (2011) N Engl J Med , vol.364 , pp. 7
    • Bern, C.1
  • 9
    • 0036359943 scopus 로고    scopus 로고
    • A critical review on Chagas disease chemotherapy
    • Coura JR, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:21.
    • (2002) Mem Inst Oswaldo Cruz , vol.97 , pp. 21
    • Coura, J.R.1    De Castro, S.L.2
  • 10
    • 17544400692 scopus 로고    scopus 로고
    • Long-term evaluation of etiological treatment of Chagas disease with benznidazole
    • Cançado JR. Long-term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 2002; 44:8.
    • (2002) Rev Inst Med Trop Sao Paulo , vol.44 , pp. 8
    • Cançado, J.R.1
  • 12
    • 33646847271 scopus 로고    scopus 로고
    • Long-term outcomes of treating chronic Chagas disease with benznidazole versus no treatment
    • Viotti R, Vigliano C, Bertocchi G, et al. Long-term outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med 2006; 144:10.
    • (2006) Ann Intern Med , vol.144 , pp. 10
    • Viotti, R.1    Vigliano, C.2    Bertocchi, G.3
  • 13
    • 34248531970 scopus 로고    scopus 로고
    • Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: Parasitological, serological, and clinical evolution
    • Fabbro DL, Streiger Ml, Arias ED, Bizai ML, del Barco M, Amicone NA. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological, and clinical evolution. Revista de Sociedade Brasileira de Medicina Tropical 2007; 40:10.
    • (2007) Revista de Sociedade Brasileira de Medicina Tropical , vol.40 , pp. 10
    • Fabbro, D.L.1    Streiger, M.L.2    Arias, E.D.3    Bizai, M.L.4    Del Barco, M.5    Amicone, N.A.6
  • 14
    • 84942265029 scopus 로고    scopus 로고
    • Randomized trial of benznidazole for chronic Chagas' cardiomyopathy
    • Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic Chagas' cardiomyopathy. N Engl J Med 2015; 373:1295-306.
    • (2015) N Engl J Med , vol.373 , pp. 1295-1306
    • Morillo, C.A.1    Marin-Neto, J.A.2    Avezum, A.3
  • 16
    • 36148997207 scopus 로고    scopus 로고
    • Evaluation and treatment of Chagas disease in the United States: A systematic review
    • Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:10.
    • (2007) JAMA , vol.298 , pp. 10
    • Bern, C.1    Montgomery, S.P.2    Herwaldt, B.L.3
  • 18
    • 84926664889 scopus 로고    scopus 로고
    • Tolerance of benznidazole in a United States Chagas disease clinic
    • Miller DA, Hernandez S, Rodriguez De Armas L, et al. Tolerance of benznidazole in a United States Chagas disease clinic. Clin Infect Dis 2015; 60:1237-40.
    • (2015) Clin Infect Dis , vol.60 , pp. 1237-1240
    • Miller, D.A.1    Hernandez, S.2    Rodriguez De Armas, L.3
  • 19
    • 84991011812 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. NewsBites: Spotlight on CDC's Parasitic Disease Work. Atlanta, GA: CDC
    • Centers for Disease Control and Prevention. Coming together on Chagas disease. NewsBites: Spotlight on CDC's Parasitic Disease Work. Atlanta, GA: CDC, 2015.
    • (2015) Coming Together on Chagas Disease
  • 20
    • 84990884650 scopus 로고    scopus 로고
    • Tratamiento de la enfermedad de Chagas crónica en Chile Efectos adversos de nifurtimox [in Spanish]
    • Valencia CN, Mancilla M, Ramos D, et al. Tratamiento de la enfermedad de Chagas crónica en Chile. Efectos adversos de nifurtimox [in Spanish]. Rev Ibero-Laintoam Parasitol 2012; 71:11.
    • (2012) Rev Ibero-Laintoam Parasitol , vol.71 , pp. 11
    • Valencia, C.N.1    Mancilla, M.2    Ramos, D.3
  • 21
    • 84949673066 scopus 로고    scopus 로고
    • Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults
    • Olivera MJ, Cucunuba ZM, Alvarez CA, Nicholls RS. Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults. Am J Trop Med Hyg 2015; 93:1224-30.
    • (2015) Am J Trop Med Hyg , vol.93 , pp. 1224-1230
    • Olivera, M.J.1    Cucunuba, Z.M.2    Alvarez, C.A.3    Nicholls, R.S.4
  • 22
    • 84877661272 scopus 로고    scopus 로고
    • Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment
    • Perez-Molina JA, Sojo-Dorado J, Norman F, et al. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment. Acta Trop 2013; 127:101-4.
    • (2013) Acta Trop , vol.127 , pp. 101-104
    • Perez-Molina, J.A.1    Sojo-Dorado, J.2    Norman, F.3
  • 26
    • 84992144353 scopus 로고    scopus 로고
    • National Cancer Institute. Bethesda, MD: U.S. Department of Health and Human Services
    • National Cancer Institute. Common Terminology Criteria for Adverse Events, version 4.03. Bethesda, MD: U.S. Department of Health and Human Services, 2010.
    • (2010) Common Terminology Criteria for Adverse Events, Version 4.03
  • 27
    • 33748669644 scopus 로고    scopus 로고
    • Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
    • Castro JA, Montalto de Mecca M, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol 2006; 25:8.
    • (2006) Hum Exp Toxicol , vol.25 , pp. 8
    • Castro, J.A.1    Montalto De Mecca, M.2    Bartel, L.C.3
  • 28
    • 0025126590 scopus 로고
    • Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes
    • Teixeira AR, Silva R, Cunha Neto E, Santana JM, Rizzo LV. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J Comp Pathol 1990; 103:11.
    • (1990) J Comp Pathol , vol.103 , pp. 11
    • Teixeira, A.R.1    Silva, R.2    Cunha Neto, E.3    Santana, J.M.4    Rizzo, L.V.5
  • 29
    • 84924031840 scopus 로고    scopus 로고
    • Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia
    • Bianchi F, Cucunubia Z, Guhl F, et al. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia. PLoS Negl Trop Dis 2015; 9.
    • (2015) PLoS Negl Trop Dis , pp. 9
    • Bianchi, F.1    Cucunubia, Z.2    Guhl, F.3
  • 30
    • 84953853524 scopus 로고    scopus 로고
    • Current drug therapy and pharmaceutical challenges for Chagas disease
    • Bermudez J, Davies C, Simonazzi A, Pablo Real J, Palma S. Current drug therapy and pharmaceutical challenges for Chagas disease. Acta Trop 2016; 156:1-16.
    • (2016) Acta Trop , vol.156 , pp. 1-16
    • Bermudez, J.1    Davies, C.2    Simonazzi, A.3    Pablo Real, J.4    Palma, S.5
  • 31
    • 84942914027 scopus 로고    scopus 로고
    • Toxic profile of benznidazole in patients with chronic Chagas disease: Risk factors and comparison of the product from two different manufacturers
    • Molina I, Salvador F, Sanchez-Montalva A, et al. Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers. Antimicrob Agents Chemother 2015; 59:6125-31.
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 6125-6131
    • Molina, I.1    Salvador, F.2    Sanchez-Montalva, A.3
  • 32
    • 0346971251 scopus 로고    scopus 로고
    • Accessed 13 May
    • Bayer AG. Chagas disease. Available at: http://pharma.bayer.com/en/commitmentresponsibility/ neglected-diseases/chagas-disease/. Accessed 13 May 2016.
    • (2016) Chagas Disease
    • Bayer, A.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.